Krishna Institute of Medical Sciences (KIMS) is moving from management contracts to ownership stakes in four regional hospitals. This consolidation in Andhra Pradesh, Telangana, and Maharashtra supports the company's aggressive goal of reaching 9,600 beds. Investors are closely monitoring how this strategy affects profit margins, which have been pressured by high expansion costs.
Krishna Institute of Medical Sciences (KIMS) is significantly shifting its operational approach to strengthen its hospital network. On October 6, 2026, the company announced that it is transitioning from its role as an operations and management partner to becoming a direct equity owner in four hospitals located in Guntur, Kakinada, Kompally, and Sangli. This move allows the company to secure controlling or significant stakes in facilities where it already provides management services.
The strategic shift is designed to consolidate its presence within established clusters in Andhra Pradesh, Telangana, and Maharashtra. By moving from a service-fee model to full or partial ownership, the company aims to have better control over quality and long-term operational efficiency. To ensure transparency, the company also released a clarification on October 7, 2026, to correct minor details regarding the financial metrics of these target entities from its initial filing.
This expansion is a key part of the company's broader effort to increase its total capacity to 9,600 beds. To fund this growth while maintaining a healthier balance sheet, KIMS successfully raised ₹1,500 crore through a qualified institutional placement in June 2026. This move helped bring down the company's consolidated debt to approximately ₹2,400 crore by July 2026. While the company reported a strong revenue growth of 36.1% year-on-year to ₹1,196 crore in the first quarter of FY27, the focus of the market has also shifted toward profitability.
There is a notable trade-off between this rapid expansion and profit margins. EBITDA margins stood at 20.1% in the first quarter of FY27, which is a decline from the 26% level reported in FY24. This pressure on margins is largely attributed to the high operational costs associated with entering new geographies and the initial phase of integrating new facilities. Expanding through existing partners is intended to lower integration risks compared to opening entirely new greenfield projects, but the company still faces the challenge of absorbing these assets without diluting overall profitability.
Looking ahead, the main test for the management will be how effectively they integrate these four units into their existing system. As the healthcare sector faces intense competition, particularly in major urban clusters, the company will need to balance its aggressive capital spending with the need to stabilize profit margins. Investors will likely track the company's ability to drive better returns from these newly acquired assets and whether it can return to higher margin levels in the coming quarters.